ES395814A1 - Cyclopentane derivatives - Google Patents

Cyclopentane derivatives

Info

Publication number
ES395814A1
ES395814A1 ES395814A ES395814A ES395814A1 ES 395814 A1 ES395814 A1 ES 395814A1 ES 395814 A ES395814 A ES 395814A ES 395814 A ES395814 A ES 395814A ES 395814 A1 ES395814 A1 ES 395814A1
Authority
ES
Spain
Prior art keywords
radical
carbon atoms
formula
substituent
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES395814A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of ES395814A1 publication Critical patent/ES395814A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4015Esters of acyclic unsaturated acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Procedure for obtaining prostanoic acid derivatives, of general formula: **(See formula)** in which R1 is a hydroxy radical, an amino radical, an alkylamino radical that can have up to 6 carbon atoms, an alkoxy radical of 1 to 6 carbon atoms or an alkoxy radical of 2 to 3 carbon atoms that has as its substituent a β- or γ -diakylamino radical, where each alkyl radical has from 1 to 4 carbon atoms, a β- or γ -pirrodilino, piperidino or morpholino radical; R2 is a hydrogen atom, or R2 and R3 together form the oxo radical; R4 is an n-hexyl radical bearing a straight chain alkyl substituent with 1 to 4 carbon atoms on any of the carbon atoms 1 to 5 of the hexyl radical, or a methyl, ethyl, methylene, ethylidene or vinyl substituent, or one methyl and one methylated substituent, or two methyl substituents on carbon atom 6 of the n-hexyl radical; and A is an ethylene or vinylene radical; and in those compounds where R1 is a hydroxy radical, the base addition salts acceptable for pharmaceutical uses thereof, characterized in that it comprises: (a) the hydrolysis of a compound of the formula: **(See formula)** or a mixed anhydride thereof, where R1 has the meaning indicated above, R2 is a hydroxy radical, an alkanoyloxy radical of 1 to 4 carbon atoms or a tetrahydropyran-2-yloxy radical and R3 is a hydrogen atom, or R2 and R3 together form the oxo radical, A and R4 have the meanings above, and R5 and R6 are each a tetrahydropyran-2-yloxy radical, or an acyloxy radical of 1 to 6 carbon atoms; or (b) In those compounds where R1 is an alkoxy radical of 1 to 6 carbon atoms, the reaction of an acid of the formula: **(See formula)** where A, R2, R3 and R4 have the meanings indicated above, with a diazoalkane of the formula R7.N2, where R7 is an alkyl radical of 1 to 6 carbon atoms; or (c) the reaction of a lactol of the formula: **(See formula)** with a (4-carboxybutyl) triphenylphosphonium salt, where A and R4 have the meanings indicated above; after which, when a salt of a compound in which R1 is a hydroxy radical is needed, the carboxylic acid is reacted with a base. (Machine-translation by Google Translate, not legally binding)
ES395814A 1970-10-09 1971-10-07 Cyclopentane derivatives Expired ES395814A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB48131/70*2A GB1356581A (en) 1970-10-09 1970-10-09 Cyclopentane derivatives
GB181471 1971-01-14
GB554371 1971-02-26

Publications (1)

Publication Number Publication Date
ES395814A1 true ES395814A1 (en) 1975-03-01

Family

ID=27253947

Family Applications (1)

Application Number Title Priority Date Filing Date
ES395814A Expired ES395814A1 (en) 1970-10-09 1971-10-07 Cyclopentane derivatives

Country Status (10)

Country Link
BE (1) BE773728A (en)
DE (1) DE2150361A1 (en)
ES (1) ES395814A1 (en)
FR (1) FR2110335B1 (en)
GB (1) GB1356581A (en)
HU (1) HU163414B (en)
IL (1) IL37821A0 (en)
NL (1) NL7113880A (en)
SU (1) SU439962A3 (en)
ZM (1) ZM14271A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3887587A (en) * 1972-04-17 1975-06-03 Pfizer Synthesis of prostaglandins of the one-series
DE2317019A1 (en) * 1972-04-27 1973-11-08 Upjohn Co NEW 4,5 DIDEHYDRO PROSTAGLANDIN
US3954741A (en) * 1972-06-07 1976-05-04 Pfizer Inc. N-substituted prostaglandin carboxamides
GB1520522A (en) * 1975-06-16 1978-08-09 Ono Pharmaceutical Co 16-methyleneprostaglandins
US5236907A (en) * 1988-10-01 1993-08-17 R-Tech Ueno Ltd. Ocular hypotensive agents
US6420422B1 (en) 1987-09-18 2002-07-16 Sucampo Pharmaceuticals, Inc. Ocular hypotensive agents
US5194429A (en) * 1988-10-01 1993-03-16 K.K. Ueno Seiyaku Oyo Kenkyujo Ocular hypotensive agents
DE68918391T2 (en) * 1988-10-01 1995-01-19 Ueno Seiyaku Oyo Kenkyujo Kk Eyepieces hypotensive means.
EP2084124B9 (en) 2006-10-02 2015-07-01 Techfields Biochem Co. Ltd Positively charged water-soluble prodrugs of prostaglandins and related compounds with very high skin penetration rates
JP6030168B2 (en) * 2015-03-09 2016-11-24 テックフィールズ バイオケム カンパニー リミテッド Positively charged water-soluble prodrugs of prostaglandins and related compounds with very high skin permeability
JP6306067B2 (en) * 2016-01-08 2018-04-04 テックフィールズ バイオケム カンパニー リミテッド Positively charged water-soluble prodrugs of prostaglandins and related compounds with very high skin permeability
JP7141025B1 (en) * 2021-11-11 2022-09-22 エルデシエロ プライベート リミテッド Compounds, compositions, methods, and methods of manufacture

Also Published As

Publication number Publication date
BE773728A (en) 1972-04-10
ZM14271A1 (en) 1972-06-21
FR2110335B1 (en) 1975-06-06
NL7113880A (en) 1972-04-11
DE2150361A1 (en) 1972-04-13
GB1356581A (en) 1974-06-12
IL37821A0 (en) 1971-11-29
HU163414B (en) 1973-08-28
SU439962A3 (en) 1974-08-15
FR2110335A1 (en) 1972-06-02

Similar Documents

Publication Publication Date Title
ES395814A1 (en) Cyclopentane derivatives
ES394370A1 (en) Pharmacologically active 3-piperazinyl-carbonyloxy-2-pyridyl-isoindolin-1-ones
ES456279A1 (en) 16,17,18,19,20-pentanorprostaglandins
ES402627A1 (en) Procedure for the obtaining of prostate acid derivatives. (Machine-translation by Google Translate, not legally binding)
ES413639A1 (en) Dopamine derivatives
ES426303A1 (en) Procedure for the obtaining of oxazolidine derivatives. (Machine-translation by Google Translate, not legally binding)
ES414343A1 (en) Cyclopentane derivatives
ES381577A1 (en) Hexahydro-fluoren-2-yloxy alkanoic acids and esters thereof
ES396210A1 (en) Phosphorus-containing polyers
ES395958A1 (en) Hydroxyaryl amino acids
ES310250A1 (en) Procedure for the preparation of new derivatives of piperidine and its homologos. (Machine-translation by Google Translate, not legally binding)
ES397453A1 (en) Imidazoline derivatives of benzonorbornane and tetrahydronaphthalene compounds
ES394504A1 (en) Cycloalkyl(f)(l)benzopyrans
ES383342A1 (en) P-carbamoylethylphenylsulfonyl derivatives
ES383108A1 (en) Procedure for the preparation of new derivatives of dibenzociclopropapenteen. (Machine-translation by Google Translate, not legally binding)
ES420666A1 (en) (1-methyl-5-nitro-2-imidazolyl)thioalkanoic acids and derivatives
ES413742A1 (en) Derivatives of alpha-halo-alpha-benzyl propionic acid
ES377995A1 (en) Procedure for the preparation of new derivatives of imidazolidinone. (Machine-translation by Google Translate, not legally binding)
ES438725A1 (en) Prostadienoic acid derivatives
ES394036A1 (en) 17alpha-hydroxy and acyloxy substituted-9alpha-methyl-19-norprogesterones
ES397708A1 (en) Procedure for the obtaining derivatives of imidazolidinone. (Machine-translation by Google Translate, not legally binding)
ES428624A1 (en) Procedure for the preparation of pyrimidine derivatives. (Machine-translation by Google Translate, not legally binding)
ES414747A1 (en) Procedure for the preparation of antibiotics. (Machine-translation by Google Translate, not legally binding)
ES449458A1 (en) A method to produce benzaliciclic acid derivatives. (Machine-translation by Google Translate, not legally binding)
ES379617A1 (en) A process for the manufacture of amino acids and derivatives thereof